OA13.02 Global Phase 2 Randomized Trial of BNT327 (Pumitamig; PD-L1 x VEGF-A bsAb) + Chemotherapy for 1L ES-SCLC: Dose Optimization Analysis
J.V. Heymach, B.C. Cho, A. Sezer, Cengiz Karaçin et autres
us, kr, tr, au, gb, de (code pays fourni par la source)